Svoboda | Graniru | BBC Russia | Golosameriki | Facebook

Comorbidity among anxiety disorders: implications for treatment and DSM-IV

J Consult Clin Psychol. 1992 Dec;60(6):835-44. doi: 10.1037//0022-006x.60.6.835.

Abstract

Research on comorbidity among psychological disorders is relatively new. Yet, comorbidity data have fundamental significance for classification and treatment. This significance is particularly apparent in the anxiety disorders, which, prior to DSM-III-R, were subsumed under disorders considered more significant (e.g., psychotic and depressive disorders). After considering definitional, methodological, and theoretical issues of comorbidity, data on comorbidity among the anxiety disorders are reviewed as well as data on comorbidity of anxiety disorders with the depressive, personality, and substance use disorders. Treatment implications are presented with preliminary data on the effects of psychosocial treatment of panic disorder on co-morbid generalized anxiety disorder. Implications of comorbidity for research on the nature of psychopathology and the ultimate integration of dimensional and categorical features in our nosology are considered.

Publication types

  • Review

MeSH terms

  • Anxiety Disorders / diagnosis
  • Anxiety Disorders / psychology
  • Anxiety Disorders / therapy*
  • Combined Modality Therapy
  • Comorbidity
  • Depressive Disorder / diagnosis
  • Depressive Disorder / psychology
  • Depressive Disorder / therapy
  • Humans
  • Mental Disorders / diagnosis
  • Mental Disorders / psychology
  • Mental Disorders / therapy*
  • Panic Disorder / diagnosis
  • Panic Disorder / psychology
  • Panic Disorder / therapy
  • Personality Disorders / diagnosis
  • Personality Disorders / psychology
  • Personality Disorders / therapy
  • Psychiatric Status Rating Scales*
  • Psychotherapy*
  • Substance-Related Disorders / diagnosis
  • Substance-Related Disorders / psychology
  • Substance-Related Disorders / therapy